This program provides a brief history around the pandemic, and addresses several topic areas related to COVID-19. These topics include the identification of risk factors for developing COVID-19, prevention strategies to share with patients, and potential roles of various medications and vaccines in the prevention/management of COVID-19.
- Pharmacy Technicians
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
REGISTRATION NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below:
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
Requirements for CE Credit
Upon registration of this program, participants will be given access to a program posttest. To receive continuing pharmacy education credit participants need to view the program content, then complete the posttest, and finally a program evaluation. Participants must score at least a 70% on the posttest before given access to the program evaluation. Once the program evaluation has been submitted credit will automatically be uploaded to CPE Monitor.
Upon successful registration you will be returned to this program page and given access to Course Materials section.
- Review features of the origin, epidemiology and impact of the SARS-CoV-2 virus (P/T)
- Identify risk factors for developing COVID 19 infection (P/T)
- Discuss preventative strategies that pharmacists should practice and share with patients to reduce risks for COVID 19 infection (P)
- Describe the potential role for various medications and vaccines in the prevention and management of COVID 19 infection (P/T)
Dennis Williams, PharmD
Brief Bio : Dennis M. Williams, PharmD, is Associate Professor of Pharmacotherapy in the School of Pharmacy, the University of North Carolina (UNC), at Chapel Hill. He is also a Clinical Specialist of pulmonary medicine at UNC Hospitals. Dr. Williams earned his pharmacy degree at the University of Kentucky College of Pharmacy in Lexington, where he received his Doctorate of Pharmacy degree in 1981. He is board certified in pharmacotherapy practice and is a certified asthma educator. Dr. Williams is a member of the American Society of Health-System Pharmacists, the American Pharmaceutical Association, the North Carolina Association of Pharmacists, and the American College of Clinical Pharmacy, among others. He has served on the Joint Committee of the American Pharmacists Association and American College of Allergy, Asthma and Immunology, and as a consultant to the Orange County Health Department and the Health Sciences Consortium. He has been a co-investigator or principal investigator in numerous research trials. His work has been published in many medical publications and journals, among them The Journal of Asthma, the Journal of the American Pharmaceutical Association, the American Journal of Health-System Pharmacy, and the Pharmaceutical Development and Technology. Dr. Williams is a member of the editorial advisory boards for Asthma and Allergies and the Journal of Pharmacy Practice and is a reviewer for the American Journal of Managed Care, the American Journal of Health-System Pharmacy, and Clinical Pharmacy, among others. He has also lectured widely on the topics of asthma, inhalation therapies, and effective patient education.
Release Date: May 1, 2020
Credit Expiration Date: May 1, 2021